Furthermore, we investigated the impact of combined inhibition of GLI, FLT3 and PI3K in primary AML blasts of FLT3-mutated (n=5) as well as FLT3 wildtype AML patients (n=12). Here, FLT3 is linked to acute myeloid leukemia.